modulate the activity of ionic channels, including voltage-gated calcium channels and glutamatergic NMDA receptors, whereas its effects on GABAergic neurotransmission had not been studied before. In the present work, we analyzed the effects of L-cysteine on responses mediated by homomeric GABA A q1 receptors, which are known for mediating tonic c-aminobutyric acid (GABA) responses in retinal neurons. GABA A q1 receptors were expressed in Xenopus laevis oocytes and GABA-evoked chloride currents recorded by two-electrode voltage-clamp in the presence or absence of L-cysteine.
L-Cysteine antagonized GABA A q1 receptormediated responses; inhibition was dose-dependent, reversible, voltage independent, and susceptible to GABA concentration. Concentration-response curves for GABA were shifted to the right in the presence of L-cysteine without a substantial change in the maximal response. L-Cysteine inhibition was insensitive to chemical protection of the sulfhydryl groups of the q1 subunits by the irreversible alkylating agent N-ethyl maleimide. Our results suggest that redox modulation is not involved during L-cysteine actions and that L-cysteine might be acting as a competitive antagonist of the GABA A q1 receptors. Keywords: GABA receptor, GABA A q1 receptors, L-cysteine, retina. J. Neurochem. (2018) 144, 50--57.
L-Cysteine (L-Cys) is an endogenous sulfur containing amino acid that plays key roles in the central nervous system (CNS). Under physiological conditions, it is a rate-limiting precursor for glutathione synthesis and takes part in the maintenance of the redox balance (Armstrong et al. 2004; Banerjee 2012; Lu 2013) .
L-Cys can exert contrasting effects on brain and retina, including neuroprotective and antioxidant activities (Miyamoto et al. 1989; de Melo Reis et al. 2007) , as well as neurotoxic actions which were suggested to be involved in the pathogenesis of neurological disorders such as amyotrophic lateral sclerosis, Parkinson 0 s and Alzheimer 0 s disease, hypoxic/ischemic and hypoglycemic brain damage and retinal degeneration (Pedersen and Karlsen 1980; Karlsen and Pedersen 1982; Heafield et al. 1990; Slivka and Cohen 1993; Jan aky et al. 2000; Gazit et al. 2004; Sawamoto et al. 2004 ). These and other evidence (Peana et al. 2010; McBean et al. 2015) , together with the fact that L-Cys is present in many dietary supplements (McPherson and Hardy 2011) , indicate that effects of L-Cys on neurotransmission might have clinical importance.
L-Cys was also proposed as neuromodulator, based on studies showing that it is released on depolarization in a Ca 2+ -dependent manner from rat brain slices (Keller et al. 1989) and produces synaptic actions, like inhibition of glutamate reuptake, activation of glutamate NMDA receptors or modulation of the activity of voltage-gated calcium channels (Ferkany and Coyle 1986; Pace et al. 1992; Nelson et al. 2005) . However, the possible targets and action mechanisms of L-Cys throughout the CNS are not entirely understood and its actions on pre or post-synaptic elements of the GABAergic synapses had not been examined before.
GABA A receptors are c-aminobutyric acid (GABA)-gated pentameric chloride (Cl À ) channels, members of the Cys-loop receptor superfamily, mediating most of the inhibitory neurotransmission in the CNS (Farrant and Nusser 2005) . Functionally distinct neuronal GABA A receptors arise from the combination of a variety of subunit subtypes (a1-6, b1-3, c1-3, d, e, p, h, q1-3). For example, heteromeric GABA A a1b2c2 receptors are widely localized in brain and retina, where they mediate desensitizing ionic currents typically antagonized by bicuculline and modulated by benzodiazepines and barbiturates (Olsen and Sieghart 2009) . Meanwhile homomeric GABA A q receptors, which are typically involved in several modes of inhibitory signaling in the retina (Matthews et al. 1994; Lukasiewicz et al. 2004; Jones and Palmer 2009) , display high affinity for GABA and mediate non-desensitizing responses which are highly resistant to bicuculline (Cutting et al. 1991; Polenzani et al. 1991; Naffaa et al. 2017) . GABA A q receptors are highly expressed in retinal bipolar cells (W€ assle et al. 1998; McCall et al. 2002) . They play an important role in the control of axon terminal excitability mediating reciprocal synapses with amacrine cells (Dong and Werblin 1998 
Materials and methods
Experiments were carried out in accordance with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the US National Institutes of Health (https://grants.nih.gov/grants/ olaw/Guide-for-the-Care-and-Use-of-Laboratory-Animals.pdf), and were approved by the Institution's Animal Care and use Committee.
RNA preparation, oocyte isolation, and cell injection Human cDNA encoding the q1 GABA A receptor subunit, cloned in the in vitro transcription-suitable vector pGEM, was used as a template to synthesize cRNAs in vitro. cRNA solutions (0.3-1 ng/nL) were prepared in RNAse-free H 2 O and stored at -70°C. Xenopus laevis (Nasco, Modesto, CA, USA) oocytes at stages V and VI were used for expression of exogenous cRNAs. Isolation and maintenance of cells were carried out as previously described (Goutman et al. 2005) . Briefly, frogs were anesthetized with 3-aminobenzoic-acid ethylester (~1 mg/mL) and ovaries surgically removed. Ovaries were incubated with 400 U/mL collagenase for 4 h at 23-24°C and isolated oocytes maintained in an incubator at 18°C in Barth's medium (in mM: 88 NaCl; 0.33 Ca(NO 3 ) 2 ; 0.41 CaCl 2 ; 1 KCl; 0.82 MgSO 4 ; 2.4 NaHCO 3 ; 10 HEPES, 0.05 mg/mL gentamicin and 0.05 mg/mL tetracycline; pH adjusted to 7.4 with NaOH). After 1 day, each oocyte was manually microinjected (microinjector Drummond Sci. Co., Broomall, PA, USA) with 50 nL of a solution containing 5-50 ng of cRNA.
Electrophysiological recordings
TEVC recordings were performed 3-7 days after oocyte injection, with an Axoclamp 2B amplifier (Axon Instruments, Union City, CA, USA). Standard glass recording electrodes were made in a Narishige PB-7 puller (Narishige Scientific Instrument Lab., Tokyo, Japan) and filled with 3 M KCl. Pipette resistance values were approximately 1 MO. The holding potential was set to À70 mV and current traces acquired by a PC through a Labmaster TL-1 DMA interface (Scientific solutions Inc., Solon, OH, USA) using AXOTAPE software (Axon Instruments). I-V curves consisted of voltage stepped ramps from À120 to +40 mV, in 2 s steps, starting from a holding potential of À70 mV. Ramps were delivered at the plateau of the GABA responses, in the presence or absence of L-Cys. Leak currents were estimated through voltage ramps performed on the baseline (before and after GABA application) and then were digitally subtracted. Cells were placed in a chamber (volume 100 lL) continuously superfused (12 mL/min) with frog Ringer's solution (in mM: 115 NaCl; 2 KCl; 1.8 CaCl 2 ; 5 HEPES; pH 7.0). GABA and other drugs were applied through the perfusion system. Drugs were freshly prepared each day as concentrated stocks and dissolved in frog Ringer 0 s solution. The pH of each test solution was always checked and adjusted if necessary to pH = 7.0. All the experiments were carried out at room temperature (23-24°C) and were replicated in at least five different oocytes isolated from at least two different frogs.
Materials
The transcription kit mMessage mMachine was purchased from Ambion (Austin, TX, USA) and type II collagenase from Worthington (Freehold, NJ, USA). All chemicals and salts were purchased from Sigma-Aldrich (St Louis, MO, USA).
Data analysis
Data were analyzed with Prism v. 6.0 (Graphpad Software, Inc. San Diego, CA, USA). Concentration-response curves for GABA were fit with a logistic equation of the following form:
n )] 9 100 where A is the agonist concentration, B the maximal response, EC 50 the concentration of agonist that elicits half-maximal responses and n the Hill coefficient. Percentage of control response was calculated as [(I GABAq1L-Cys 9 100/ I GABAq1control )], where I GABAq1L-Cys indicates the current amplitude evoked at each particular GABA concentration in the presence of LCys and I GABAq1control the corresponding responses in the absence of modulator. Percentage of inhibition was calculated as [100 À (I GABAAq1L-Cys 9 100/I GABAAq1control )]. Student 0 s t-tests (two tailed) were employed to evaluate significant differences between parameters. In all cases errors were expressed as SEM.
Results
Inhibition of GABA-mediated currents by L-cysteine GABA applications to oocytes expressing homomeric GABA A q1 receptors induced non-desensitizing inward Cl À currents displaying all features of the bicuculline resistant GABA receptor mediated responses typically found in the retina (Polenzani et al. 1991; Zhang et al. 2001; Hull et al. 2006) . They were antagonized by (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA) and picrotoxin and displayed the characteristic pharmacological profile for agonists (data not shown) (Kusama et al. 1993; Woodward et al. 1993; Ragozzino et al. 1996; Naffaa et al. 2017) . Figure 1 illustrates the effects of L-Cys on GABA A q1 receptor-mediated responses evoked by 1 lM GABA, a concentration close to the EC 50 of GABA for these receptors, at À70 mV. Short bath applications of L-Cys significantly inhibited GABA responses ( Fig. 1a and b) . Antagonistic actions were dose-dependent, showed fast onset and completely reversed after washout. In the absence of GABA, L-Cys applications (200 lM) performed on either mRNAinjected or sham oocytes did not produce noticeable effects on oocyte properties such as membrane potential, membrane resistance or current baseline under voltage-clamp (n = 7; data not shown). No changes in the degree of inhibition were observed when consecutive GABA-evoked responses (1 lM GABA) were recorded in the continued presence of a single concentration of L-Cys (200 lM) (Fig. 1c) , indicating that LCys effects on GABA A q1 receptors are not use-dependent (Goutman and Calvo 2004) . Concentration-response (C-R) curves for GABA were performed either in the absence or presence of L-Cys ( Fig. 2a ; parameters detailed in Table 1 ). L-Cys shifted the C-R curve for GABA to the right, that is increased the EC 50 without a substantial change in the maximal response. These results indicated that in the presence of L-Cys the apparent affinity of GABA A q1 receptors decreased. L-Cys inhibition strongly depended on GABA concentration (Fig. 2b) , with the degree of antagonism declining as GABA concentration increased. Currents evoked by 0.3 lM GABA were inhibited in a 76.8 AE 4.4% (n = 8, p < 0.0001), whereas currents evoked by 10 lM GABA were inhibited in a 2.6 AE 0.9% (n = 13, ns). For GABA concentrations lower than 3 lM, inhibition induced by 200 lM L-Cys was always significant (p < 0.001). The effects of increasing doses of L-Cys were tested on responses evoked by different GABA concentrations: 0.3 lM (A), 1 lM (B) and 10 lM (C) (n = 5-10) (Fig. 2c) . The effects of L-Cys on GABA A q1 receptormediated responses were particularly pronounced at GABA concentrations within the dynamic range of activation, but almost negligible at saturating values of GABA. At 0.3 lM GABA, inhibition was significant for all L-Cys concentrations tested (10 lM to 3 mM) and at 1 lM GABA, effects were significant for concentrations above 20 lM (n = 6, p < 0.02). Meanwhile, at 10 lM GABA, inhibition was only significant for levels of L-Cys above 500 lM (n = 10, p < 0.02).
Current-voltage relationships (I-V curves), performed in the presence or absence of 200 lM L-Cys, showed a change in the slope without alterations in the linearity of the I-V relationship or the reversal potential (between À120 and 40 mV for 1 lM GABA-elicited responses), demonstrating that effects on GABA A q1 receptors did not depend on the membrane potential and neither were because of variations in intracellular Cl À levels (Fig. 2d) .
Modulation of GABA A q1 receptors by L-cysteine is not affected by N-ethyl-maleimide treatment L-Cys had been previously shown to be a redox modulator of T-type calcium channels in rat peripheral nociceptors (Todorovic et al. 2001; Nelson et al. 2005) . In addition, we had also observed that reducing and oxidizing thiol agents are effective modulators of the GABA A q1 receptor function (Calero and Calvo 2008; Gasulla et al. 2012; Beltr an Gonz alez et al. 2014 ). In fact, many different ionic channels sensitive to redox modulation usually are chemically modified through oxidation of cysteine residues. Based on all these data, we decided to test if redox modulation of cysteine residues might also be involved in the actions of LCys on GABA A q1 receptors. At first view, the rapid onset and reversible effect of L-Cys on the GABA A q1 receptor mediated responses would be consistent with a direct redox modulatory action and thiol groups located at the q1 subunits would be the most reactive redox candidates.
Each q1 subunit contains only two molecular sites contributing potential reactive cysteines, namely the extracellular Cys-loop and the single intracellular (C364) (Sedelnikova et al. 2005; Lo et al. 2008) . However, it is important to state that redox modulation of the GABA A q1 receptors mediated by these cysteine residues was sensitive to N-ethyl-maleimide (NEM) treatment in all cases examined before (Calero et al. 2011; Gasulla et al. 2012; Beltr an Gonz alez et al. 2014) . NEM is a membrane permeable irreversible alkylating reagent which selectively forms covalent bonds with free sulfhydryl groups, preventing any further chemical reaction at these sites (at pH = 7.0) (Means and Feeney 1971) . During the present experiments NEM concentration was kept as low as possible and incubation periods maintained very short in order to avoid nonspecific effects (Calero et al. 2011) . Pre-incubation for 2 min with 30 lM and 300 lM NEM failed to prevent L-Cys induced inhibition (% Control Response L-Cys = 32.7 AE 4.7% (n = 5), + NEM 30 lM = 40.1 AE 6.8% (n = 6), + NEM 300 lM = 40.8.1 AE 6.4% (n = 6), ns) (Fig. 3) . Taken together, these results suggest that redox modulation is not involved during GABA A q1 responses inhibition by L-Cys.
GABA A q1 receptors function is insensitive to L-cystine and L-homocysteine
The specificity of L-Cys actions on GABA A q1 responses was analyzed by testing the closely related compounds L-cystine and L-homocysteine, which also have physio-pathological relevance (Cherqui et al. 2002; Mattson and Shea 2003; Isobe et al. 2005; Ajith and Ranimenon 2015) and whose actions on GABA A q1 receptor mediated responses had not been previously examined. Application of L-cystine (200 lM) did not produce significant effects on responses elicited by 0.3 lM (103.8 AE 5.3% (n = 8) ns) or 1 lM GABA (101.7 AE 1.2% (n = 5) ns). L-Homocysteine (200 lM) showed no significant effect either on responses elicited by 0.3 lM (107.7 AE 6.3% (n = 5) ns) or 1 lM GABA (99.3 AE 0.8% (n = 6) ns). Representative experiments are illustrated in Fig 4. 
Discussion
The present findings are the first to demonstrate that the ubiquitous and endogenous amino acid L-Cys can modulate the function of GABA A receptors. Our results show that LCys is capable to induce functional changes on homomeric GABA A q1 receptors, a GABA A receptor subtype highly expressed in the retina that mediates tonic GABA responses in bipolar cells.
Mechanisms underlying the inhibition of GABA A q1 receptors by L-cysteine Inhibition of GABA A q1 receptors by L-Cys was reversible, dose-dependent, voltage-independent and strongly susceptible to GABA concentration. The rapid onset of inhibition was consistent with an extracellular mechanism of action taking place. Experiments with NEM suggested that antagonistic actions of L-Cys are not because of redox modulation of cysteine residues at the GABA A q1 receptors. Interactions of thiol compounds, like L-Cys, with traces of transition metal ions can potentially generate oxygen freeradical species by Haber-Weiss type reactions (Jan aky et al. 2000) . However, an indirect action of L-Cys on GABA A q1 receptors through this mechanism seems not to be the case, because previous studies in our laboratory showed that oxygen free radicals potentiated GABA A q1 responses with a slow onset through an interaction with the intracellular cysteine residues of the q1 subunits (Beltr an Gonz alez et al. 2014), in sharp contrast to the fast inhibition observed here following L-Cys applications. L-Cys induced a rightward parallel shift in the C-R curve for GABA without changing the maximum response and the Hill coefficient. In addition, GABA A q1 receptor antagonism by L-Cys was surmounted by increasing the GABA concentration and did not involve use-dependent processes. Taken together, these results suggest that L-Cys shares the characteristics of other competitive antagonists acting on the GABA A q1 receptors (Woodward et al. 1993) . However, binding studies will be necessary to confirm this assumption. Finally, neither L-cystine nor L-homocysteine, structural analogs of L-Cys, had effect on GABA A q1 responses evoked at concentrations in which L-Cys exhibited significant effects. Thus, structural determinants are essential for L-Cys modulation.
Possible physiological relevance of the modulation of ionotropic GABA A q1 receptors by L-cysteine GABA A q1 receptors provide significant inhibitory drive to the synaptic terminals of retinal bipolar cells, including tonic, reciprocal and lateral inhibition (Zhang and Slaughter 1995; Lukasiewicz et al. 2004; Hull et al. 2006; Ch avez et al. 2010) . In this context, the inhibition of GABA A q1 receptors responses by L-Cys could eventually increase the excitability of the bipolar cells, shaping ganglion cell responses and raising the excitability of the visual pathway. However, whether or not L-Cys modulation represents a relevant mechanism for controlling the activity of these and other ionotropic GABA receptors in retinal neuronal circuits, under physiological or pathological conditions, will need to be assessed using both retinal slices and in vivo models.
The study of endogenous agents, such as L-Cys, as modulators of ionotropic GABA receptors broadens the understanding of the control of the phasic and tonic GABAergic neurotransmission and could eventually shed light on the etiology of several neurological disorders and the development of therapeutic applications. The extracellular concentrations of L-Cys used here were far below the range of those commonly used in previous work (Pace et al. 1992; Todorovic et al. 2001; Nelson et al. 2005) . Even though effects on GABA Ap 1 receptors were significant L-Cys is normally found in relatively low levels in brain (ca. 0.05 lmol/g), compared for example to the cysteine-containing tripeptide, glutathione (ca. 1.5 lmol/g). However, L-Cys was estimated to reach up to a level equivalent to a concentration of 700 lM in the course of ischemic brain damage (Slivka and Cohen 1993) . In our study, antagonistic actions of L-Cys on GABA A q1 receptors were detected even at 35-fold lower concentration than that. Given the potential clinical relevance of L-Cys effects on GABA neurotransmission, the extensive use of L-Cys as food additive or nutraceutical (McPherson and Hardy 2012) , together with the fact that ionotropic GABA receptors are the most important inhibitory receptors in the brain, it will be important in future studies to establish if L-Cys can serve as signaling mediator regulating the activity of different GABA A receptors subtypes in the CNS.
